NCT06757621View on ClinicalTrials.gov

Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

3,142

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

November 1, 2029

Study Completion Date

November 1, 2032

Conditions
Breast Carcinoma
Interventions
RADIATION

Regional Nodal Irradiation

Patients will receive chest wall / breast radiation with or without regional nodal irradiation

Trial Locations (1)

12345

RECRUITING

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER